According to the latest enforcement report issued by the US Food and Drug Administration (USFDA), the US-based arm of Aurobindo Pharma is recalling 1,15,776 bottles of Moxifloxacin Ophthalmic Solution, an antibiotic used in the treatment of bacterial infections.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/wVQYeL9
via IFTTT
Home »
Healthcare/Biotech-Industry-Economic Times
» Aurobindo, Sun Pharma recall products in US market
0 comments:
Post a Comment